Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
279
-
Total 13F shares, excl. options
-
102M
-
Shares change
-
+5.81M
-
Total reported value, excl. options
-
$3.83B
-
Value change
-
+$143M
-
Put/Call ratio
-
0.23
-
Number of buys
-
163
-
Number of sells
-
-110
-
Price
-
$37.53
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q1 2024
327 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q1 2024.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 279 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102M shares
of 114M outstanding shares and own 89.17% of the company stock.
Largest 10 shareholders include FMR LLC (12.9M shares), VANGUARD GROUP INC (9.1M shares), BAILLIE GIFFORD & CO (7.42M shares), ARK Investment Management LLC (6.28M shares), BlackRock Inc. (6.01M shares), MORGAN STANLEY (5.16M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.66M shares), Sumitomo Mitsui Trust Holdings, Inc. (3.62M shares), Nikko Asset Management Americas, Inc. (3.62M shares), and SANDS CAPITAL MANAGEMENT, LLC (3.38M shares).
This table shows the top 279 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.